Yue-Qiang Li Selected Research

1- (4- (2- methoxyethyl)phenoxy)- 3- (((2- 2- methoxyphenoxy)ethyl)amino)- 2- propanol

1/2013

TJ0711, a novel vasodilatory β-blocker, protects SHR rats against hypertension induced renal injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue-Qiang Li Research Topics

Disease

4	Fibrosis (Cirrhosis) 01/2021 - 01/2014
3	IGA Glomerulonephritis (IGA Nephropathy) 03/2020 - 01/2015
1	Hypercholesterolemia 01/2022
1	Proteinuria 01/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022
1	Microvascular Rarefaction 01/2021
1	Myocardial Infarction 01/2021
1	Atrophy 03/2020
1	Inflammation (Inflammations) 01/2019
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2015
1	Reperfusion Injury 08/2014
1	Chronic Renal Insufficiency 01/2014
1	Hypertension (High Blood Pressure) 01/2013

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	Chemotactic FactorsIBA 03/2020 - 01/2019
1	oxidized low density lipoproteinIBA 01/2022
1	CholesterolIBA 01/2022
1	HDL CholesterolIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Phospholipase A2 ReceptorsIBA 01/2022
1	CytokinesIBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	LigandsIBA 03/2020
1	CXC ChemokinesIBA 03/2020
1	Uric Acid (Urate)IBA 03/2020
1	Chemokine CX3CL1IBA 01/2019
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2015
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2014
1	Telmisartan (Micardis)FDA Link 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Carvedilol (Coreg)FDA LinkGeneric 01/2013
1	Therapeutic UsesIBA 01/2013
1	1- (4- (2- methoxyethyl)phenoxy)- 3- (((2- 2- methoxyphenoxy)ethyl)amino)- 2- propanolIBA 01/2013

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2022
1	Therapeutics 01/2013